Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Judy P. Tsai"'
Autor:
David S. Morgan, Deepa Jagadeesh, Brian T. Hill, Judy P. Tsai, Robert M. Dean, Brad Pohlman, Van T Nguyen, Mitchell R. Smith, John P. Greer, Priyanka A. Pophali, Nishitha Reddy
Publikováno v:
British Journal of Haematology. 179:674-676
Publikováno v:
Leukemia & Lymphoma. 56:797-800
Per institutional investigator ’ s choice, patients older than age 65 or with signifi cant comorbidities were treated with DA-R-EPOCH (dose-adjusted rituximab plus etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin). Conversely, y
Autor:
Mahsa S. Talbott, Megan L. Hames, Wade T. Iams, Kristy L. Richards, Nishitha Reddy, Kimberly B. Dahlman, Judy P. Tsai
As the use of lenalidomide expands, the poorly understood phenomenon of lenalidomide-induced thyroid abnormalities will increase. In this study, we compared rates of therapy-induced hypothyroidism in 329 patients with diffuse large B-cell lymphoma (D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::767507a172b9c5841d73c7286a7a4239
Autor:
Timothy S. Fenske, Aliyah R. Sohani, Haowei Linda Sun, Michael Jaglal, Scott E. Smith, Adam M. Petrich, Caitlin Handler, Shruthi Melinamani, Andrew D. Zelenetz, Ryan D. Cassaday, Khushboo A Shah, Jeremy D. Whyman, Andrew M. Evens, David Peace, Jeremy S. Abramson, Oliver W. Press, L. Jeffrey Medeiros, Kevin W. Song, Francisco J. Hernandez-Ilizaliturri, Saurabh Rajguru, Nishitha Reddy, Christopher R. Flowers, David T. Yang, Anthony R. Mato, Shaoying Li, Kristie A. Blum, Stefan K. Barta, Julio C. Chavez, Borko Jovanovic, Lisa X Lee, Chadi Nabhan, Julie M. Vose, Daniel J. Landsburg, Jonathon B. Cohen, Reem Karmali, Camille Adeimy, Judy P. Tsai, Jorge J. Castillo, Christina Howlett, Frederick Lansigan, Mitul Gandhi, Namrata Shah, Neil Dalal, Jesse Jaso
Publikováno v:
Blood. 124(15)
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a retrospective multicenter study of the impact of baseline clinical factors, induction therapy, and s
Publikováno v:
Blood. 124:5430-5430
Background: Prior studies have demonstrated the utility of involved field radiation therapy to reduce relapse rates and improve local control in Hodgkin Lymphoma (HL). The standard treatment for early stage unfavorable HL is combined modality approac
Autor:
Kimberly B. Dahlman, Megan L. Hames, Mahsa S. Talbott, Judy P. Tsai, Wade T. Iams, Nishitha Reddy, Kristy L. Richards
Publikováno v:
Blood. 124:4438-4438
Background: The use of lenalidomide is expanding to include patients with refractory or relapsed diffuse large B cell lymphoma (DLBCL). Lenalidomide is less toxic than thalidomide, but it leads to hypothyroidism in approximately 5-10% of patients tha
Publikováno v:
Blood. 122:4361-4361
Background Double-hit (DH) diffuse large B cell lymphomas (DLBCL), characterized by concurrent translocations involving MYC and BCL2, or BCL6, portend to have an aggressive clinical course. Recent studies have highlighted the fact that DH lymphomas a